EventsThe 1st International Online Conference on Bioengineering
Published
This submission belongs to the session 5. Biosignal Processing of the event The 1st International Online Conference on Bioengineering
Published date
11 Oct, 2024
Academic Editor
author-avatarAndrea Cataldo
Citation
MD Jiabul Hoque, Mohammad Nadib Hasan, Md. Humayun Kabir, Arup Ratan Kuri, A M Tanbir Lahib, Mitigating Human Error in Breast Cancer Diagnosis with Deep Learning, in Proceedings of The 1st International Online Conference on Bioengineering, 16 October–18 October 2024, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Mitigating Human Error in Breast Cancer Diagnosis with Deep Learning

Mohammad Nadib Hasan 1
Md. Humayun Kabir 1
1. Department of Computer and Communication Engineering, International Islamic University Chittagong, Bangladesh, Bangladesh
Abstract

The prompt and precise detection of breast cancer, a substantial worldwide health issue, is essential for enhancing patient results. Nevertheless, conventional techniques such as mammography encounter constraints in terms of sensitivity and specificity, resulting in overlooked diagnoses and unwarranted biopsies. Deep learning (DL) is a state-of-the-art technique that can improve breast cancer detection by effectively extracting complex characteristics from medical images and enabling precise categorization. This research introduces a novel framework designed for the nuanced categorization of breast cancer by analyzing histopathology images using DL techniques. The journey begins with the original histopathological images employing a substantial dataset comprising approximately 150,408 image patches of two separate categories based on the presence or absence of invasive ductal carcinoma (IDC), each with dimensions of 50x50 pixels and RGB colour representation. The system underwent rigorous pre-processing steps and employed data augmentation to reduce overfitting. These augmented images serve as the input for the fine-tuned DL models, a repertoire that includes Custom CNN, ResNet50, DenseNet201, and VGG16, all orchestrated for meticulous training, testing, and validation. After carefully analyzing the pre-trained models and custom CNN, we found that the fine-tuned VGG16 model had an exceptional performance, obtaining an accuracy rate of 96%. The proposed approach was subjected to thorough examination, confirming its efficacy and ability to reduce diagnostic errors caused by human factors.

Keywords
Breast cancer
Regenerative tissue
Deep learning
CNN
IDC
ResNet50
DenseNet201
VGG16
Two-way FSI analysis of additive manufactured CoCr stent
Layer-by-layer assembly for manufacturing local chemotherapy platforms with controlled and sustained drug release to prevent local tumor relapse